Advertisement

Collaboration › Details
Consilium–Westwicke Partners: public relations, 201704– collab joint venture for healthcare-focused US IR advisory
![]() |
Period | 2017-04-10 |
![]() |
Region | United States (USA) |
![]() |
Partner, 1st | Consilium Strategic Communications Ltd. (CSC) |
Today | ICR Consilium Strategic Communications | |
Group | ICR (Group) | |
Partner, 2nd | Westwicke Partners LLC | |
Today | Westwicke, an ICR Company | |
Group | ICR (Group) | |
![]() |
Product | public relations / investor relations / marcom (services) |
Product 2 | healthcare | |
![]() |
Person | Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) |
Person 2 | McDonald, Tom (Westwicke Partners 2017 Managing Director) | |
Consilium Strategic Communications Ltd.. (4/10/17). "Press Release: Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory". London & Baltimore, MD.
Consilium Strategic Communications, a global leader in strategic healthcare communications, today announces a joint venture with Westwicke Partners, the largest independent healthcare-focused investor relations and capital markets advisory firm in the US.
Consilium and Westwicke already support a number of shared clients and the new joint venture will see the two teams work more closely together to provide healthcare focused investor relations advisory and communications programmes in the US and internationally.
Consilium and Westwicke have offices in London, Baltimore, Boston, New York, San Diego, and San Francisco.
Mary-Jane Elliott, Managing Partner of Consilium Strategic Communications, commented: “We are pleased to be formalising our relationship with Westwicke which further expands our international offering in US IR and strengthens our ability to reach the increasingly important US investor community.”
Tom McDonald, Managing Director at Westwicke Partners, said: “Consilium has established itself as the leading independent strategic communications consultancy in Europe. Their team is known as a leader in the international healthcare sector and we are delighted to be building on our already strong relationship through this new joint venture.”
For more information please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
info@consilium-comms.com
Follow us: @consiliumhc
Westwicke Partners
Tom McDonald
Tel: +1 443-213-0508
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications advisory with offices in London and across the US. Consilium's highly-skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects.
About Westwicke Partners
Westwicke Partners provides customized strategic investor relations programs and independent capital markets advice to public and private healthcare companies. Westwicke focuses on the healthcare sector exclusively, and is headquartered in Baltimore with regional offices in Boston, New York, San Diego, and San Francisco.
Contact
Europe
Consilium Strategic Communications
41 Lothbury
London
EC2R 7HG
+44 (0)20 3709 5700
email info@consilium-comms.com
United States
Westwicke Partners
477 Madison Avenue, Suite 621
New York
NY 10022
+1 (443) 213-0500
email info@consilium-comms.com
Westwicke Partners
132 Chief Justice Cushing Highway
Cohasset
MA 02025
+1 (443) 213-0500
email info@consilium-comms.com
Record changed: 2023-09-13 |
Advertisement

More documents for ICR (Group)
- [1] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [2] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [3] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
- [4] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [5] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [6] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
- [7] Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London....
- [8] Oasmia Pharmaceutical AB. (8/10/20). "Press Release: Oasmia Pharmaceutical Appoints Peter Selin as Chief Business Officer". Uppsala....
- [9] Consilium Strategic Communications Ltd.. (9/26/19). "Press Release: Consilium Strategic Communications Expands International Senior Team with Four New Appointments". London & Boston, MA....
- [10] Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top